158 related articles for article (PubMed ID: 7799569)
1. [Investigation on the treatment of infection due to Mycobacterium Kansasii].
Nakazono T; Sugie T; Ogata H; Mizutani S; Sugita H; Kino T; Wada M
Kekkaku; 1994 Oct; 69(10):587-92. PubMed ID: 7799569
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy of pulmonary Mycobacterium kansasii infection].
Mizutani S
Kekkaku; 1996 Sep; 71(9):527-31. PubMed ID: 8914388
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of non-tuberculous pulmonary mycobacteriosis].
Sakatani M; Nakajima Y
Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
[TBL] [Abstract][Full Text] [Related]
5. [Retreatment of pulmonary tuberculosis--duration of chemotherapy].
Wada M; Seita A; Mori T; Ogata H; Sugie T; Sugita H
Kekkaku; 1993 Jul; 68(7):469-78. PubMed ID: 8361115
[TBL] [Abstract][Full Text] [Related]
6. [Clinical investigation of pulmonary Mycobacterium kansasii infection in our hospital].
Tao Y; Ninomiya K; Miyazaki M; Aizawa H
Kekkaku; 2002 Jan; 77(1):23-7. PubMed ID: 11855075
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features of pulmonary Mycobacterium kansasii infection: comparison with M. tuberculosis and M. avium complex infection].
Matsushita Y; Niimi A; Tanaka E; Amitani R; Kurasawa T; Kawai M; Kuze F
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1507-14. PubMed ID: 8121086
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and follow up of 302 patients with Mycobacterium kansasii pulmonary infection: a 50 year experience.
Maliwan N; Zvetina JR
Postgrad Med J; 2005 Aug; 81(958):530-3. PubMed ID: 16085747
[TBL] [Abstract][Full Text] [Related]
9. [Mycobacterium kansasii lung infection associated with myelofibrosis--a case refractory to treatment with antitubercular agents].
Umeda A; Asano K; Kawai A; Nakamura H; Fujita H; Mori M; Yamaguchi K; Kanazawa M
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec; 32(12):1170-4. PubMed ID: 7853774
[TBL] [Abstract][Full Text] [Related]
10. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy].
Shigeto E; Murakami I; Yokosaki Y
Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329
[TBL] [Abstract][Full Text] [Related]
11. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
[TBL] [Abstract][Full Text] [Related]
12. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
13. Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study.
Griffith DE; Brown-Elliott BA; Wallace RJ
Clin Infect Dis; 2003 Nov; 37(9):1178-82. PubMed ID: 14557961
[TBL] [Abstract][Full Text] [Related]
14. [Perspective of pulmonary MAC infection treatment].
Kurashima A
Kekkaku; 2007 Mar; 82(3):195-9. PubMed ID: 17444124
[TBL] [Abstract][Full Text] [Related]
15. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
16. [Pulmonary infection by Mycobacterium kansasii. Presentation of 27 cases (1988-1992)].
Echevarría MP; Martín G; Pérez J; Urkijo JC
Enferm Infecc Microbiol Clin; 1994; 12(6):280-4. PubMed ID: 8080864
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapeutic regimens that were considered effective to cure pulmonary infection caused by Mycobacterium avium-Mycobacterium intracellulare complex].
Tsukamura M
Kekkaku; 1991 May; 66(5):375-80. PubMed ID: 1875580
[TBL] [Abstract][Full Text] [Related]
18. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
Kobashi Y; Oka M
Kekkaku; 2008 Dec; 83(12):779-84. PubMed ID: 19172823
[TBL] [Abstract][Full Text] [Related]
19. [Primary infection type atypical mycobacteriosis (lung infection) in the Fuji City Central Hospital during 1989-94].
Imaizumi T
Kekkaku; 1997 Jun; 72(6):415-21. PubMed ID: 9248276
[TBL] [Abstract][Full Text] [Related]
20. [Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease].
Kobashi Y; Okimoto N; Matsushima T; Shigetou E; Kuraoka T; Takeyama H; Eda R; Yano S; Kobayashi K; Ohnishi T; Mori K; Ueda Y; Moritaka T; Nishimura K; Abe T
Kekkaku; 2002 Jun; 77(6):435-41. PubMed ID: 12136597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
